On October 13, FDA contacted companies who had previously registered their facilities to be eligible to ship to China to request confirmation of specific details of the registration information for each facility. The full text of that FDA request can be found here.  

FDA has requested companies with facilities already registered for export to China to review the current listing of each facility on the CNCA website.  FDA is requesting companies ensure the names of the products listed for each of your facilities matches one of the names listed on the CNCA list of acceptable product names.   

Additionally, FDA is requesting companies verify each listed facility is currently capable of producing the products listed on the CNCA website.  Once verification of the information listed for each facility is complete, firms are requested to email Esther Lazar (esther.lazar@fda.hhs.gov), confirming all of the details are correct or noting any changes that must be made.   

Companies are requested to email, using company letterhead. Companies are also asked to include the address of each facility, with either a confirmation that the listed details are correct (for each facility) or, products requested to be added or removed from the list (for each facility), as appropriate.     

For those companies not currently on the CNCA list, FDA is requesting you review your registration application and confirm the products listed in your application conform to the CNCA product names and that your facility is currently capable of producing those products.   

Once verification of the information listed for each facility is complete, firms are requested to email Esther Lazar (esther.lazar@fda.hhs.gov), either confirming all of the details are correct or noting any changes that must be made. Companies are requested to email, using company letterhead, and include the address of each facility with either a confirmation that the details are correct (for each facility) or, products requested to be added or removed from the list (for each facility), as appropriate.     

FDA is requesting companies verify all facility information by November 2, 2015.  

For further information contact mmcknight@usdec.org or mbowling@usdec.org.